PRGOT Stock Price, News & Analysis

PRGOT

Company Description

PRGOT (NYSE: PRGOT) is a publicly traded company.

This page provides a comprehensive overview of PRGOT stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

Performance 1 year

$0.0

Market Cap

0.0

Shares outstanding

Latest News

View All

March 17, 2022

—

PERRIGO ANNOUNCES U.S. FDA APPROVAL FOR OTC USE OF NASONEX® 24HR ALLERGY

fda approval

February 15, 2022

—

PERRIGO TO RELEASE FOURTH QUARTER AND FISCAL YEAR 2021 FINANCIAL RESULTS ON MARCH 1, 2022

earnings

November 10, 2021

—

Perrigo Reports Third Quarter 2021 Financial Results From Continuing Operations

earnings

October 27, 2021

—

Perrigo To Release Third Quarter 2021 Financial Results On November 10, 2021

earnings

October 5, 2021

—

Perrigo Announces New Consumer Self-Care Americas (CSCA) Leadership

September 29, 2021

—

Perrigo Resolves Irish Tax Assessment for €297 million

PRGOT has 10 recent news articles. Key topics include fda approval, earnings, conferences, dividends. View all PRGOT news →

SEC Filings

View All

No SEC filings available for PRGOT.

Financial Highlights

View Full Financials

—

Revenue (TTM)

—

Net Income (TTM)

—

Diluted EPS (TTM)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months